Polygon Management »

Tenax Therapeutics shares owned by Polygon Management

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Polygon Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 75k 14.55

More positions owned by Polygon Management

Uipath Cl A (PATH)
Kolibri Global Energy Com New (KGEI)
Autolus Therapeutics Spon Ads (AUTL)
Lyft Cl A Com (LYFT)
Definium Therapeutics Com Shs (DFTX)
Workiva Com Cl A (WK)
Silence Therapeutics Ads Call Option (SLN)
Sprinklr Cl A (CXM)
Mbx Biosciences (MBX)
Alkami Technology (ALKT)
Celldex Therapeutics Com New (CLDX)
Relay Therapeutics (RLAY)
Arrowhead Pharmaceuticals (ARWR)
Pharvaris N V (PHVS)
Alkermes SHS (ALKS)

View all positions for Polygon Management

Top funds holding Tenax Therapeutics

FMR
T. Rowe Price Associates
Vivo Capital
Henderson Group
BlackRock
Perceptive Advisors
Ikarian Capital
Vanguard Capital Management
Citadel Advisors
Millennium Management
Candriam Luxembourg S.C.A.
Caption Management
Rtw Investments
Stonepine Capital Management
Geode Capital Management

View all funds holding Tenax Therapeutics